26 employees
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
2020
$51M
from 2 investors over 2 rounds
Walden Biosciences raised $51M on October 6, 2020
Investors: UCB Ventures and ARCH Venture Partners